22nd Century Group Announces South Korea as First International VLN® Market

Content of the article

First revenue from shipping to market partner expected by end of March 2022

Advertising

Content of the article

BUFFALO, NY, Feb. 28 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, tobacco nicotine reduction, and improved health and welfare through modern plant science, today announced $1.6 billion1 The South Korean tobacco market will be the first international market to start sales of its VLN® reduced nicotine cigarettes.

“South Korea is an ideal international launch market in many ways, with a high smoking rate among developed countries and a government strongly committed to tobacco harm reduction. We are waiting for the first sale of VLN® reduced nicotine cigarettes to our South Korean partner by the end of March,” said James A. Mish, President and CEO.

Advertising

Content of the article

“About one in three adult men in South Korea2 smoke and about 6% of adult women smoke. The government has worked over the past two decades to promote smoking cessation through various means, including raising tobacco prices, and remains committed to advancing alternative products to help curb smoking activity in the country. . We are excited to do VLN® reduced nicotine products available in South Korea to help break the cycle of nicotine addiction and support this important effort.

The Company will continue its process of launching in additional markets in Asia and Europe with limited regulatory barriers while leveraging VLN®MRTP’s authorization to seek approval in additional markets with higher regulatory barriers. In addition to its first international launch of VLN® Reduced Nicotine Cigarettes in a Global Tobacco Market of Over $800 Billion, 22nd Century Group is Actively Moving Forward to Launch VLN® in the $80 billion US tobacco market. The US FDA has cleared 22nd Century’s VLN® reduced nicotine cigarette products on December 23, 2021. The company is currently executing its 90-day post-approval plan to launch in its first US pilot market.

Advertising

Content of the article

In its MRTP Authorization Press Release for the 22nd Century VLN® King and VLN® Menthol King Cigarettes, the FDA said, “We know that three out of four adult smokers want to quit, and data on these products show they can help addicted adult smokers move away from highly addictive combustion cigarettes.”

About VLN®
VLN® is the first and only combustible cigarette approved by the FDA MRTP. Using proprietary tobacco plant lines from 22nd Century, VLN® cigarettes smoke, smell and taste like a conventional cigarette, but contain 95% less nicotine. Numerous independent scientific studies, largely funded by the United States Food and Drug Administration, the National Institutes of Health and other United States federal government agencies, have demonstrated that the use of low nicotine cigarettes such as VLN® helps smokers reduce their nicotine exposure and addiction, smoke fewer cigarettes per day, increase their number of smoke-free days, and double their quit attempts, all with little to no withdrawal symptoms to nicotine or compensatory smoking behavior. VLN® helps you smoke less. Learn more at tryVLN.com.

Advertising

Content of the article

About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology company focused on reducing tobacco harm, reducing tobacco nicotine, and improving health and well-being through phytology. With dozens of patents enabling it to control the biosynthesis of nicotine in the tobacco plant, the company has developed proprietary reduced nicotine (RNC) tobacco plants and cigarettes, which have become the cornerstone of the overall plan. of the FDA to combat widespread deaths and illnesses caused by smoking. The company received the first and only MRTP clearance from the FDA for a combustible cigarette in December 2021. In tobacco, hemp/cannabis and hops plants, 22nd Century uses modern plant breeding technologies including genetic engineering , gene editing and molecular breeding to provide solutions for the life science and consumer product industries by creating new proprietary plants with optimized alkaloid and flavonoid profiles along with improved yields and valuable agronomic characteristics.

Advertising

Content of the article

Learn more at xxiicentury.com, on Twitter @_xxiicentury and on LinkedIn.

Caution Regarding Forward-Looking Statements
Except for historical information, all statements, expectations and assumptions in this press release are forward-looking statements. Forward-looking statements generally contain words such as “anticipate”, “believe”, “consider”, “continue”, “could”, “estimate”, “expect”, “explore”, “expect”, “target ‘, ‘advice’, ‘intend’, ‘likely’, ‘may’, ‘plan’, ‘potential’, ‘predict’, ‘preliminary’, ‘probable’, ‘project’, ‘promising’, “seek”, “should”, “steal”, “would” and similar expressions. Actual results may differ materially from those expressed or implied in the forward-looking statements. Important factors that could cause actual results to differ materially are discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K filed March 11, 2021. All information provided in this release is valid. as of the date hereof, and The Company undertakes no obligation and does not intend to update these forward-looking statements, except as required by law.

Advertising

Content of the article

Investor Relations and Media Contact:
Mei Kuo
22nd Century Group, Inc.
Director, Communications and Investor Relations
Phone. : +1-716-300-1221
[email protected]

Darrow Associates Investor Relations
Matt Kreps
Phone. : +1-214-597-8200
[email protected]


1
https://www.statista.com/outlook/cmo/tobacco-products/south-korea

2
https://www.statista.com/statistics/645282/south-korea-smoking-rate-by-gender/#:~:text=In%202019%2C%20about%2034.7%20percent,declined%20steadily%20in% 20recent%20years.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5875eade-e524-411f-930e-283f7a995009

Advertising

comments

Postmedia is committed to maintaining a lively yet civil discussion forum and encourages all readers to share their views on our articles. Comments can take up to an hour to be moderated before appearing on the site. We ask that you keep your comments relevant and respectful. We have enabled email notifications. You will now receive an email if you receive a reply to your comment, if there is an update to a comment thread you follow, or if a user follows you comments. See our Community Guidelines for more information and details on how to adjust your email settings.

About Margaret Shaw

Check Also

Premier Manufacturing launches a new look for 1839 cigarettes

Photo courtesy of US Tobacco Cooperative RALEIGH, North Carolina — Premier Manufacturing launches a new …